{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:52:41Z","timestamp":1781927561023,"version":"3.54.5"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,6,15]]},"DOI":"10.2169\/internalmedicine.6120-25","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T22:06:12Z","timestamp":1763589972000},"page":"1594-1600","source":"Crossref","is-referenced-by-count":0,"title":["Characteristics of Patients with Primary Hyperparathyroidism with Localization Failure of the Causative Parathyroid Gland: A Clinical Report and Literature Review"],"prefix":"10.2169","volume":"65","author":[{"given":"Kai","family":"Takedani","sequence":"first","affiliation":[{"name":"Department of Internal Medicine 1, Shimane University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Notsu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 1, Shimane University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keizo","family":"Kanasaki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 1, Shimane University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bilezikian JP, Khan AA, Silverberg SJ, et al.; International Workshop on Primary Hyperparathyroidism. Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth International Workshop. J Bone Miner Res 37: 2293-2314, 2022.","DOI":"10.1002\/jbmr.4677"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kowalski GJ, Bu\u0142a G, \u017b\u0105d\u0142o D, Gawrychowska A, Gawrychowski J. Primary hyperparathyroidism. Endokrynol Pol 71: 260-270, 2020.","DOI":"10.5603\/EP.a2020.0028"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yeh MW, Ituarte PH, Zhou HC, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab 98: 1122-1129, 2013.","DOI":"10.1210\/jc.2012-4022"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Rolighed L, Vestergaard P, Heickendorff L, et al. BMD improvements after operation for primary hyperparathyroidism. Langenbecks Arch Surg 398: 113-120, 2013.","DOI":"10.1007\/s00423-012-1026-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Seib CD, Meng T, Suh I, et al. Risk of fracture among older adults with primary hyperparathyroidism receiving parathyroidectomy vs nonoperative management. JAMA Intern Med 182: 10-18, 2022.","DOI":"10.1001\/jamainternmed.2021.6437"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Mollerup CL, Vestergaard P, Fr\u00f8kjaer VG, Mosekilde L, Christiansen P, Blichert-Toft M. Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ 325: 807, 2002.","DOI":"10.1136\/bmj.325.7368.807"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Reid L, Muthukrishnan B, Patel D, et al. Presentation, diagnostic assessment and surgical outcomes in primary hyperparathyroidism: a single centre&apos;s experience. Endocr Connect 7: 1105-1115, 2018.","DOI":"10.1530\/EC-18-0195"},{"key":"8","unstructured":"8. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843: 1-129, 1994."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Cusano NE, Cetani F. Normocalcemic primary hyperparathyroidism. Arch Endocrinol Metab 66: 666-677, 2022.","DOI":"10.20945\/2359-3997000000556"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kushchayeva YS, Tella SH, Kushchayev SV, Van Nostrand D, Kulkarni K. Comparison of hyperparathyroidism types and utility of dual radiopharmaceutical acquisition with Tc99m sestamibi and <sup>123<\/sup>I for localization of rapid washout parathyroid adenomas. Osteoporos Int 30: 1051-1057, 2019.","DOI":"10.1007\/s00198-019-04846-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sukan A, Reyhan M, Aydin M, et al. Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging. Ann Nucl Med 22: 123-131, 2008.","DOI":"10.1007\/s12149-007-0086-z"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Boi F, Lombardo C, Cocco MC, et al. Thyroid diseases cause mismatch between MIBI scan and neck ultrasound in the diagnosis of hyperfunctioning parathyroids: usefulness of FNA-PTH assay. Eur J Endocrinol 168: 49-58, 2012.","DOI":"10.1530\/EJE-12-0742"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Chandramohan A, Sathyakumar K, Irodi A, Abraham D, Paul MJ. Causes of discordant or negative ultrasound of parathyroid glands in treatment na\u00efve patients with primary hyperparathyroidism. Eur J Radiol 81: 3956-3964, 2012.","DOI":"10.1016\/j.ejrad.2012.08.019"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Madkhali T, Alhefdhi A, Chen H, Elfenbein D. Primary hyperparathyroidism. Ulus Cerrahi Derg 32: 58-66, 2016.","DOI":"10.5152\/UCD.2015.3032"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Agarwal A, Traylor KS, Branstetter BF, Weyer A, McCoy KL, Muthukrishnan A. 4D SPECT\/CT: a hybrid approach to primary hyperparathyroidism. J Nucl Med Technol 52: 86-90, 2024.","DOI":"10.2967\/jnmt.123.266990"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Fiz F, Bottoni G, Massollo M, et al. [18F]F-Choline PET\/CT and 4D-CT in the evaluation of primary hyperparathyroidism: rivals or allies? Q J Nucl Med Mol Imaging 67: 130-137, 2023.","DOI":"10.23736\/S1824-4785.23.03514-8"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lo TE, Tan IT. Distal renal tubular acidosis in primary hyperparathyroidism. BMJ Case Rep 2015: bcr2014208120, 2015.","DOI":"10.1136\/bcr-2014-208120"},{"key":"18","unstructured":"18. Siddiqui AA, Wilson DR. Primary hyperparathyroidism and proximal renal tubular acidosis: report of two cases. Can Med Assoc J 106: 654-659, 1972."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Liu Y, Guo S, Sang S, et al. Differences in clinicopathological characteristics of papillary thyroid carcinoma between symptomatic and asymptomatic patients with primary hyperparathyroidism. Int J Endocrinol 2021: 9917694, 2021.","DOI":"10.1155\/2021\/9917694"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/12\/65_6120-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:37:30Z","timestamp":1781926650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/12\/65_6120-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6120-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"article-number":"6120-25"}}